These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 11222064)
1. The assessment of irradiated bladder carcinoma using dynamic contrast-enhanced MR imaging. Dobson MJ; Carrington BM; Collins CD; Ryder WD; Read G; Hutchinson CE; Hawnaur JM Clin Radiol; 2001 Feb; 56(2):94-8. PubMed ID: 11222064 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of chemotherapy with magnetic resonance imaging in patients with regionally metastatic or unresectable bladder cancer. Schrier BP; Peters M; Barentsz JO; Witjes JA Eur Urol; 2006 Apr; 49(4):698-703. PubMed ID: 16464531 [TBL] [Abstract][Full Text] [Related]
3. Accuracy of axillary MR imaging in treated breast cancer for distinguishing between recurrent tumour and treatment effects: does intravenous Gd-DTPA enhancement help in cases of diagnostic dilemma? Bradley AJ; Carrington BM; Hammond CL; Swindell R; Magee B Clin Radiol; 2000 Dec; 55(12):921-8. PubMed ID: 11124071 [TBL] [Abstract][Full Text] [Related]
5. [Determining the depth of infiltration in urinary bladder carcinoma with contrast medium enhanced dynamic magnetic resonance tomography. With reference to postoperative findings and inflammation]. Venz S; Ilg J; Ebert T; Hierholzer J; Friedrichs R; Hosten N; Felix R Urologe A; 1996 Jul; 35(4):297-304. PubMed ID: 8928358 [TBL] [Abstract][Full Text] [Related]
6. Dynamic contrast-enhanced MRI in the differentiation of posttreatment fibrosis from recurrent carcinoma of the head and neck. Semiz Oysu A; Ayanoglu E; Kodalli N; Oysu C; Uneri C; Erzen C Clin Imaging; 2005; 29(5):307-12. PubMed ID: 16153535 [TBL] [Abstract][Full Text] [Related]
7. Dynamic contrast enhanced magnetic resonance imaging of bladder cancer and implications for biological image-adapted radiotherapy. Røe K; Muren LP; Rørvik J; Olsen DR; Dahl O; Bakke A; Malinen E Acta Oncol; 2008; 47(7):1257-64. PubMed ID: 18618299 [TBL] [Abstract][Full Text] [Related]
8. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy. Haider MA; Chung P; Sweet J; Toi A; Jhaveri K; Ménard C; Warde P; Trachtenberg J; Lockwood G; Milosevic M Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):425-30. PubMed ID: 17881141 [TBL] [Abstract][Full Text] [Related]
9. Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer. Sciarra A; Panebianco V; Salciccia S; Osimani M; Lisi D; Ciccariello M; Passariello R; Di Silverio F; Gentile V Eur Urol; 2008 Sep; 54(3):589-600. PubMed ID: 18226441 [TBL] [Abstract][Full Text] [Related]
10. Dynamic magnetic resonance perfusion imaging of brain tumors. Covarrubias DJ; Rosen BR; Lev MH Oncologist; 2004; 9(5):528-37. PubMed ID: 15477637 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of gall bladder carcinoma with dynamic magnetic resonance imaging and magnetic resonance cholangiopancreatography. Kaza RK; Gulati M; Wig JD; Chawla YK Australas Radiol; 2006 Jun; 50(3):212-7. PubMed ID: 16732816 [TBL] [Abstract][Full Text] [Related]
12. Evaluating local hepatocellular carcinoma recurrence post-transcatheter arterial chemoembolization: is diffusion-weighted MRI reliable as an indicator? Goshima S; Kanematsu M; Kondo H; Yokoyama R; Tsuge Y; Shiratori Y; Onozuka M; Moriyama N J Magn Reson Imaging; 2008 Apr; 27(4):834-9. PubMed ID: 18383261 [TBL] [Abstract][Full Text] [Related]
13. [Magnetic resonance imaging findings of liver injury induced by three-dimensional conformal radiotherapy]. Chen DC; Chen LH; Jin WD; Xu YK; Xu PJ Nan Fang Yi Ke Da Xue Xue Bao; 2007 Feb; 27(2):181-3, 187. PubMed ID: 17355931 [TBL] [Abstract][Full Text] [Related]
14. Gadolinium-enhanced MRI with dynamic evaluation in diagnosing the local recurrence of rectal cancer. Torricelli P; Pecchi A; Luppi G; Romagnoli R Abdom Imaging; 2003; 28(1):19-27. PubMed ID: 12483379 [TBL] [Abstract][Full Text] [Related]
15. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images. Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357 [TBL] [Abstract][Full Text] [Related]
16. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging. Yu JS; Lee JH; Chung JJ; Kim JH; Kim KW Acta Radiol; 2008 Sep; 49(7):735-43. PubMed ID: 18608015 [TBL] [Abstract][Full Text] [Related]
17. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses. Inan N; Arslan A; Akansel G; Anik Y; Balci NC; Demirci A Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481 [TBL] [Abstract][Full Text] [Related]
18. Early glottic squamous cell carcinoma. Predictive value of MR imaging for the rate of 5-year local control with radiation therapy. Murakami R; Baba Y; Furusawa M; Nishimura R; Nakaura T; Baba T; Katsura F; Eura M; Masuyama K; Takahashi M Acta Radiol; 2000 Jan; 41(1):38-44. PubMed ID: 10665868 [TBL] [Abstract][Full Text] [Related]
19. The use of MR imaging to detect residual versus recurrent nasopharyngeal carcinoma following treatment with radiation therapy. Lin GW; Wang LX; Ji M; Qian HZ Eur J Radiol; 2013 Dec; 82(12):2240-6. PubMed ID: 24103355 [TBL] [Abstract][Full Text] [Related]
20. Intravenous contrast-enhanced dynamic MR urography: diagnosis of vesicoureteral reflux during bladder filling with time-signal intensity curves. Kocaoglu M; Bulakbasi N; Ilica AT; Gok F; Tayfun C; Somuncu I J Magn Reson Imaging; 2006 Aug; 24(2):349-55. PubMed ID: 16786563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]